LipoScience Inc  

(Public, NASDAQ:LPDX)   Watch this stock  
Find more results for lpdx
- Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.85
Shares 15.35M
Beta     -
Inst. own 63%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -49.75% -23.93%
Operating margin -44.76% -20.39%
EBITD margin - -17.29%
Return on average assets -26.51% -20.95%
Return on average equity -42.12% -305.69%
Employees 239 -
CDP Score - -


2500 Sumner Blvd
RALEIGH, NC 27616-3235
United States - Map
+1-919-2121999 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


LipoScience, Inc. is a clinical diagnostic company. The Company’s diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company’s Vantera system represents the research in the field of personalized diagnostics. The Company's NMR LipoProfile test directly quantifies low density lipoprotein particles (LDL-P) circulating in the body. As of December 31, 2013, over 11 million NMR LipoProfile tests were ordered.